WebCytokinetics is an Equal Opportunity Employer Seniority level Entry level Employment type Full-time Job function Legal Industries Biotechnology Research Referrals increase your … WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised.
Did you know?
WebFeb 27, 2024 · Cytokinetics, Inc South San Francisco, CA Cardiovascular Account Specialist – U.S. Sales (Edison, NJ)Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating d ... WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised.
Webhttp://www.cytokinetics.com Industries Biotechnology Research Company size 201-500 employees Headquarters South San Francisco, California Type Public Company … WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 …
WebContact Us. Main Telephone: (650) 624-3000. Investor Relations – [email protected]. Human Resources – [email protected]. Public Relations … WebOct 31, 2024 · SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming poster presentations at the American Heart Association ...
WebMar 31, 2024 · Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular … Pipeline - Cytokinetics Muscle Biology Therapies Home Cytokinetics, Inc. does not by its reference above or distribution imply its … Company - Cytokinetics Muscle Biology Therapies Home SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of … The key to muscle function is contraction. The principal functionality of muscle is … Heart failure affects 64 million people worldwide, hospitalizes more Americans …
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Apr 10, 2024 (GLOBE NEWSWIRE via COMTEX) -- SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- … ots turbo chinaWebCytokinetics South San Francisco, CA 3.0 ★★★★★ 55 % Recommend to a Friend 49 % Approve of CEO Robert I. Blum 14 Ratings View open jobs at this location Cytokinetics South San Francisco, CA office. 350 Oyster Point Blvd South San Francisco, CA, 94080-4808 Get Directions Cytokinetics South San Francisco, CA Reviews 5.0 ★★★★★ … ots tracksWebCytokinetics, South San Francisco, California. 539 likes · 7 talking about this · 100 were here. We are developing potential medicines to improve … otst prisonWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … rock star fabric shower curtainWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... rockstar face paintingWebJul 12, 2024 · With 20 years of research and development and $1 billion in investment, top officials at South San Francisco biotech company Cytokinetics think a medicine to … rockstar explicit lyricsWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, … ots tto pp